As of Jul 25
| -0.05 / -2.50%|
The 3 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +310.26% increase from the last price of 1.95.
The current consensus among 3 polled investment analysts is to Buy stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.